Synlait Reports $12 Million Net Loss Amid Refinancing Efforts
Synlait Milk is progressing a key refinancing of its senior bank facilities due June 2026 and plans to replace a $130 million shareholder loan with a two-year term facility. The company reports a preliminary $12 million net loss for the first four months of 2026 amid operational headwinds and asset sales.
- Refinancing of senior syndicated bank facilities on track for June 30, 2026
- Replacement of $130 million Bright Dairy shareholder loan with two-year term loan
- Preliminary net loss after tax of $12 million for January-April 2026
- North Island asset sale contributed a preliminary gain during the period
- Independent Directors Committee oversees arm’s-length negotiation of replacement loan
Refinancing Progress and Shareholder Loan Replacement
Synlait Milk Limited (ASX:SM1, NZX:SML) is advancing negotiations to refinance its senior syndicated bank facilities, which mature on 30 June 2026. The company remains on track to complete the refinancing by the deadline, working with both existing and potential new lenders to secure necessary approvals and support.
A pivotal element of the refinancing is replacing the existing $130 million shareholder loan provided by Bright Dairy International Investment Limited in July 2024. The replacement loan maintains the same principal amount but extends the term to two years without an extension option, differing from the original one-year term plus extension. The interest rate will be linked to the 3-month BKBM plus a margin aligned with the weighted average margin of Synlait’s senior facilities, adjusting after the 2027 refinancing.
Loan Terms and Governance Safeguards
The Replacement Bright Loan remains subordinated to the senior facilities and secured on a second-ranking basis behind existing security. Notably, the loan retains provisions allowing deferral of interest and principal payments under specified financial stress scenarios, consistent with the existing agreement. There are no financial covenants favoring Bright, and legacy provisions no longer applicable have been removed.
An Independent Directors Committee (IDC), chaired by George Adams and including Katherine Turner, has overseen the arm’s-length negotiation process. Bright-nominated directors, including acting CEO Leon Fung, were excluded from discussions to ensure independence. The IDC initiated and proposed the terms, demonstrating a controlled and transparent negotiation environment.
Preliminary Financial Results Reflect Operational Challenges
Synlait reported a preliminary net loss after tax of NZ$12.0 million for the four months ended 30 April 2026. This outcome follows a series of headwinds, largely concentrated in January, and reflects ongoing operational challenges as the company implements improvements and strengthens its balance sheet following the sale of its North Island assets.
The sale of these assets, completed during the period, generated a preliminary gain and was part of a broader strategy to reduce debt and refocus operations. The company’s net assets stood at NZ$720.8 million as of 30 April 2026. These figures are unaudited and cover a non-standard reporting period with no direct comparables. Synlait’s full audited results for the fiscal year ending 31 July 2026 will provide a clearer financial picture.
Implications for Synlait’s Capital Structure and Outlook
The refinancing and shareholder loan replacement are critical to Synlait’s capital structure reset, following significant operational disruptions and strategic asset sales. The two-year fixed term for the replacement loan provides a clearer medium-term funding horizon, while interest rate margins tied to senior facilities align lender interests.
Synlait’s focus remains on operational stability and balance sheet repair, but the preliminary loss signals the company is still navigating a challenging recovery phase. The finalisation of refinancing and loan documentation, alongside upcoming audited results, will be key milestones to watch.
Bottom Line?
Synlait’s refinancing and shareholder loan replacement mark important steps in its financial reset, but preliminary losses highlight ongoing operational hurdles ahead.
Questions in the middle?
- Will Synlait complete its refinancing on schedule and secure final lender approvals by June 30?
- How will the two-year fixed term of the Replacement Bright Loan influence Synlait’s liquidity and refinancing risk in 2027?
- What operational improvements will drive a return to profitability following the asset sale and reported losses?